Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials.
Huang SW, Liang YL, Tao YL, Li WF, Zhou GQ, Mao YP, Guo R, Chen L, Xu S, Liu X, Zhang N, Liu F, Shen LF, Zhou YY, Yuan YW, Zou GR, Jin F, Tang LL, Sun Y, Li YQ, Ma J, Liu N.
Huang SW, et al. Among authors: zhou yy.
J Clin Oncol. 2026 Mar 6:JCO2502111. doi: 10.1200/JCO-25-02111. Online ahead of print.
J Clin Oncol. 2026.
PMID: 41791006